ClinicalTrials.Veeva

Menu

Prognostic Nomogram of Extranodal NK/T-cell Lymphoma

Sun Yat-sen University logo

Sun Yat-sen University

Status

Enrolling

Conditions

Extranodal NK/T-cell Lymphoma

Study type

Observational

Funder types

Other

Identifiers

NCT04554511
ENKTL-2020

Details and patient eligibility

About

This study aims to evaluate prognostic factors for overall survival and explore risk progression-free survival in ENKTL, and establish a prognostic predictive nomogram for ENKTL patients.

Full description

This is a retrospective cohort study using anonymized information from patients with ENKTL. The following criteria are required: (1) Patients diagnosed with ENKTL between January 1, 2000 and August 31, 2020; (2) Patients older than 18 years. The pathology of initial diagnosis was reviewed by designated pathologists.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients newly diagnosed with ENKTL
  • Patients diagnosed between January 1, 2000 and August 31, 2020
  • Patients older than 18 years

Exclusion criteria

  • Patients who did not have complete clinical information or immunohistochemistry, or who were lost follow-up immediately after treatment.

Trial design

1,000 participants in 2 patient groups

Training cohort
Description:
Patients diagnosed with ENKTL, between January 1, 2000 and August 31, 2020.
Validation Cohort
Description:
Patients diagnosed with ENKTL, between January 1, 2000 and August 31, 2020.

Trial contacts and locations

1

Loading...

Central trial contact

Hua Wang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems